,
Daida, Yihe G. http://orcid.org/0000-0003-1628-0476
Boscarino, Joseph A.
Moorman, Anne C.
Lu, Mei
Rupp, Loralee B.
Gordon, Stuart C.
Teshale, Eyasu H.
Schmidt, Mark A.
Spradling, Philip R.
Funding for this research was provided by:
Centers for Disease Control and Prevention (1U18PS005154)
Gilead Sciences (IN-US-337-3957)
Article History
Accepted: 2 January 2020
First Online: 14 January 2020
Compliance with ethical standards
:
: Stuart C. Gordon receives grant/research support from AbbVie Pharmaceuticals, Conatus, CymaBay, Gilead Sciences, Intercept Pharmaceuticals, and Merck. He is also a consultant/advisor for Dova Pharmaceuticals and Intercept and serves as a speaker/teacher in programs sponsored by Dova. Mei Lu, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, and Loralee B. Rupp receive research grant support from Gilead Sciences and Intercept Pharmaceuticals. Eyasu H. Teshale, Anne C. Moorman, and Philip R. Spradling have no conflicts of interest to report.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was reviewed and approved by an Institutional Review Board at each participating study site.
: The IRB has waived Informed Consent and Authorization for the use of electronic health records in this study. Passive informed consent was obtained from all individual participants who completed the study survey.